John Celebi

Insider Reports History

Entity
Individual
Location
Sensei Biotherapeutics, Inc., 1405 Research Blvd., Ste. 125, Rockville, MD
Signature
/s/ Mark Ballantyne, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by John Celebi:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Sensei Biotherapeutics, Inc. PRESIDENT AND CEO, Director Common Stock 105K $83.3K $0.79 Feb 15, 2024 Direct
Sensei Biotherapeutics, Inc. PRESIDENT AND CEO, Director Stock Option (Right to Buy) 355K Dec 20, 2024 Direct

Insider Reports Filed by John Celebi

Symbol Company Period Transactions Value $ Form Type Date Filed Role
SNSE Sensei Biotherapeutics, Inc. Dec 20, 2024 1 $0 4 Dec 23, 2024 PRESIDENT AND CEO, Director
SNSE Sensei Biotherapeutics, Inc. Feb 15, 2024 3 -$4.65K 4 Feb 16, 2024 PRESIDENT AND CEO, Director
SNSE Sensei Biotherapeutics, Inc. Sep 11, 2023 1 $425 4 Sep 13, 2023 President and CEO, Director
SNSE Sensei Biotherapeutics, Inc. Feb 15, 2023 1 -$30.7K 4 Sep 11, 2023 President and CEO, Director
SNSE Sensei Biotherapeutics, Inc. Feb 15, 2023 3 $0 4/A Mar 29, 2023 President and CEO, Director
SNSE Sensei Biotherapeutics, Inc. Feb 15, 2022 2 $0 4 Feb 17, 2022 President and CEO, Director